Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults with AATD has...
Jeff Hutchins, PhD, discusses a novel mechanism that stimulates the immune system by providing the antigens it requires to recognize, target, and specifically destroy cancer cells in a “natural” way.
Co-Chair Edward Shahady, MD, FAAFP, ABCL, interviews Kevin Peterson, MD, MPH, on what happens to Beta Cells after 3 years of GLP-1 administration, compared with insulin.
Co-Chair Daniel Einhorn, MD, FACP, FACE, talks with fellow Co-Chair Edward Shahady, MD, FAAFP, ABCL about the early results of SGLT2 inhibitors and the cardiovascular benefits and cardiac outcomes.